361 related articles for article (PubMed ID: 30279971)
1. Inhibition of interleukin-1 receptor-associated kinase 1 (IRAK1) as a therapeutic strategy.
Singer JW; Fleischman A; Al-Fayoumi S; Mascarenhas JO; Yu Q; Agarwal A
Oncotarget; 2018 Sep; 9(70):33416-33439. PubMed ID: 30279971
[TBL] [Abstract][Full Text] [Related]
2. Crystal structure of human IRAK1.
Wang L; Qiao Q; Ferrao R; Shen C; Hatcher JM; Buhrlage SJ; Gray NS; Wu H
Proc Natl Acad Sci U S A; 2017 Dec; 114(51):13507-13512. PubMed ID: 29208712
[TBL] [Abstract][Full Text] [Related]
3. IL-1 receptor-associated kinase family proteins: An overview of their role in liver disease.
Wang ZY; Gao ST; Gou XJ; Qiu FR; Feng Q
Eur J Pharmacol; 2024 Jun; ():176773. PubMed ID: 38936453
[TBL] [Abstract][Full Text] [Related]
4. IRAK1 and IRAK4 as emerging therapeutic targets in hematologic malignancies.
Bennett J; Starczynowski DT
Curr Opin Hematol; 2022 Jan; 29(1):8-19. PubMed ID: 34743084
[TBL] [Abstract][Full Text] [Related]
5. IRAK family in inflammatory autoimmune diseases.
Su LC; Xu WD; Huang AF
Autoimmun Rev; 2020 Mar; 19(3):102461. PubMed ID: 31917263
[TBL] [Abstract][Full Text] [Related]
6. Both IRAK3 and IRAK1 Activate the MyD88-TRAF6 Pathway in Zebrafish.
Weng P; Lan M; Zhang H; Fan H; Wang X; Ran C; Yue Z; Hu J; Xu A; Huang S
J Immunol; 2024 Jun; ():. PubMed ID: 38847613
[TBL] [Abstract][Full Text] [Related]
7. Recent Advances in IRAK1: Pharmacological and Therapeutic Aspects.
Kim KM; Hwang NH; Hyun JS; Shin D
Molecules; 2024 May; 29(10):. PubMed ID: 38792088
[TBL] [Abstract][Full Text] [Related]
8. Dimeric Structure of the Pseudokinase IRAK3 Suggests an Allosteric Mechanism for Negative Regulation.
Lange SM; Nelen MI; Cohen P; Kulathu Y
Structure; 2021 Mar; 29(3):238-251.e4. PubMed ID: 33238146
[TBL] [Abstract][Full Text] [Related]
9. Differential regulation and role of interleukin-1 receptor associated kinase-M in innate immunity signaling.
Su J; Xie Q; Wilson I; Li L
Cell Signal; 2007 Jul; 19(7):1596-601. PubMed ID: 17379480
[TBL] [Abstract][Full Text] [Related]
10. Sequential control of Toll-like receptor-dependent responses by IRAK1 and IRAK2.
Kawagoe T; Sato S; Matsushita K; Kato H; Matsui K; Kumagai Y; Saitoh T; Kawai T; Takeuchi O; Akira S
Nat Immunol; 2008 Jun; 9(6):684-91. PubMed ID: 18438411
[TBL] [Abstract][Full Text] [Related]
11. Pacritinib Inhibition of IRAK1 Blocks Aberrant TLR8 Signalling by SARS-CoV-2 and HIV-1-Derived RNA.
Campbell GR; Rawat P; Spector SA
J Innate Immun; 2023; 15(1):96-106. PubMed ID: 35785771
[TBL] [Abstract][Full Text] [Related]
12. A novel splice variant of interleukin-1 receptor (IL-1R)-associated kinase 1 plays a negative regulatory role in Toll/IL-1R-induced inflammatory signaling.
Rao N; Nguyen S; Ngo K; Fung-Leung WP
Mol Cell Biol; 2005 Aug; 25(15):6521-32. PubMed ID: 16024789
[TBL] [Abstract][Full Text] [Related]
13. IRAK1: a critical signaling mediator of innate immunity.
Gottipati S; Rao NL; Fung-Leung WP
Cell Signal; 2008 Feb; 20(2):269-76. PubMed ID: 17890055
[TBL] [Abstract][Full Text] [Related]
14. Regulations and roles of the interleukin-1 receptor associated kinases (IRAKs) in innate and adaptive immunity.
Gan L; Li L
Immunol Res; 2006; 35(3):295-302. PubMed ID: 17172653
[TBL] [Abstract][Full Text] [Related]
15. Interleukin-1 Receptor-Associated Kinase 1/4 as a Novel Target for Inhibiting Neointimal Formation After Carotid Balloon Injury.
Bai S; Li D; Zhou Z; Cao J; Xu T; Zhang X; Wang Y; Guo J; Zhang Y
J Atheroscler Thromb; 2015; 22(12):1317-37. PubMed ID: 26310493
[TBL] [Abstract][Full Text] [Related]
16. Pivotal Advance: Inhibition of MyD88 dimerization and recruitment of IRAK1 and IRAK4 by a novel peptidomimetic compound.
Loiarro M; Capolunghi F; Fantò N; Gallo G; Campo S; Arseni B; Carsetti R; Carminati P; De Santis R; Ruggiero V; Sette C
J Leukoc Biol; 2007 Oct; 82(4):801-10. PubMed ID: 17548806
[TBL] [Abstract][Full Text] [Related]
17. Purification, crystallization and drug screening of the IRAK pseudokinases.
Lange SM; Kulathu Y
Methods Enzymol; 2022; 667():101-121. PubMed ID: 35525539
[TBL] [Abstract][Full Text] [Related]
18. Immune complex-mediated cell activation from systemic lupus erythematosus and rheumatoid arthritis patients elaborate different requirements for IRAK1/4 kinase activity across human cell types.
Chiang EY; Yu X; Grogan JL
J Immunol; 2011 Jan; 186(2):1279-88. PubMed ID: 21160042
[TBL] [Abstract][Full Text] [Related]
19. Functional Variation of IL-1R-Associated Kinases in the Conserved MyD88-TRAF6 Pathway during Evolution.
Yan X; Chen S; Huang H; Peng T; Lan M; Yang X; Dong M; Chen S; Xu A; Huang S
J Immunol; 2020 Feb; 204(4):832-843. PubMed ID: 31915260
[TBL] [Abstract][Full Text] [Related]
20. Interleukin Receptor Associated Kinase 1 Signaling and Its Association with Cardiovascular Diseases.
Zheng Y; He JQ
Rev Cardiovasc Med; 2022 Mar; 23(3):97. PubMed ID: 35345264
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
